news
CHMP recommends new immunotherapy delivery method
If approved, Roche’s Tecentriq subcutaneous (SC) would be the EU’s first injectable PD-(L)1 cancer immunotherapy.
List view / Grid view
Liver cancer
news
MSD and Nectin to collaborate on clinical trial for KEYTRUDA® combination
MSD/Merck and Nectin Therapeutics have agreed to collaborate on a clinical trial for KEYTRUDA® in combination with monoclonal antibody NTX1088.
news
AstraZeneca dual immunotherapy approved for US liver cancer patients
The FDA has approved Imfinzi™ combined with Imjudo for adults with unresectable liver cancer, based on a lower risk of death compared to only sorafenib.
news
Study finds Keytruda® improves overall survival in HCC patients
The data adds to the body of evidence relating to the use of Keytruda® as a monotherapy in second-line HCC post sorafenib.
news
Machine learning used to predict most effective cancer drugs
According to a new study, Drug Ranking Using Machine Learning (DRUML) can accurately rank cancer therapies by efficacy across a range of cancer types.
news
Novel ionic liquid enables uniform chemotherapy delivery in solid tumours
Co-injecting doxorubicin with LATTE, a novel ionic liquid formulation, resulted in uniform chemotherapy delivery and successful ablation in solid tumours.
news
Targeted radiation using TARE-Y90 for children with liver cancer
A review of a study on children with liver cancer has shown the effectiveness of Transarterial Radioembolization with Yttrium-90 as a course of treatment...
news
New micro-platform improves understanding of cancer cells
A new low-cost, cell culture platform technique may provide insight for more effective cancer treatment, according to the researchers who developed it...
news
Cone beam CT offers detailed imaging for precise RS delivery
A novel technique called radiation segmentectomy (RS), that delivers high doses of radiation to tumours while sparing the surrounding healthy tissue, shows promise as a curative treatment option for patients with early-stage liver cancer, according to a recent study.
news
T-VEC treatment shows promise for treating advanced stage liver tumours
Phase 1 data supports the use of image-guided therapy for difficult to treat cancer...
news
Acoustic Cluster Therapy drives drug therapies to cancer cells
Researchers are testing the use of pulsed sound waves to direct and focus cancer drug therapies...
news
ALA-artemisinin combination therapy for cancer identified
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment...
news
Bayer receives EU approval for Regorafenib
Bayer have announced the European Commission has granted marketing authorisation for Stivarga...
